XML 58 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions (Details) - Villaris Therapeutics, Inc. - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Nov. 17, 2022
Asset Acquisition [Line Items]    
Outstanding shares acquired   100.00%
Upfront payment $ 70.3  
Asset Acquisition, Milestone One    
Asset Acquisition [Line Items]    
Contingent consideration   $ 310.0
Asset Acquisition, Milestone Two    
Asset Acquisition [Line Items]    
Contingent consideration   $ 1,050.0